Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1Dermatologic 1

Conditions

Urinary Bladder Neoplasms 1Testicular Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Melanoma 1Bone Neoplasms 1

Interventions

Filgrastim 8Carboplatin 8Peripheral Blood Stem Cell Transplantation 6Etoposide 5Thiotepa 4Melphalan 4Cyclophosphamide 4Busulfan 4Temozolomide 3Radiotherapy 3Polymerase Chain Reaction 3Ifosfamide 3Granulocyte Colony-Stimulating Factor 3etoposide phosphate 2aflibercept 2Topotecan 2Therapeutics 2Psychiatric Rehabilitation 2Magnetic Resonance Spectroscopy 2Itraconazole 2Flow Cytometry 2Carmustine 2Bone Marrow Transplantation 2Blood Specimen Collection 2Amplified Fragment Length Polymorphism Analysis 2Amifostine 2trioctyl phosphine oxide 1tremelimumab 1trastuzumab deruxtecan 1thymoglobulin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Testicular Neoplasms × Histocompatibility Testing × Sarcoma × Clear all
NCT05819827 2025-04-27

Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics

Mayo Clinic

Terminated
13 enrolled
DermatologicGenitourinarySarcoma

Urinary Bladder Neoplasms, Melanoma, Prostatic Neoplasms, Sarcoma, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡